Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Koninklijke Philips N.V.    PHIA   NL0000009538


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Philips growth spurred by COVID-19 demand and distant care

10/19/2020 | 01:41pm EST
Philips Healthcare headquarters is seen in Best

AMSTERDAM (Reuters) - Health technology company Philips saw sales and profits jump in the third quarter, as the COVID-19 pandemic spurred demand for hospital equipment needed to help patients battling the disease.

Amsterdam-based Philips on Monday said comparable sales rose 10% to 4.98 billion euros ($5.8 billion) in the July-September period, while core profits improved by almost a third to 769 million euros.

Profits and sales easily beat analysts' expectations, taking Philips shares up 2.9% at 0800 GMT in Amsterdam.

Growth was mainly driven by a 42% increase in sales at the connected care division, which makes monitoring and respiratory care devices used to treat COVID-19 patients and other appliances which allow carers to work remotely.

Like competitors such as Germany's Siemens Healthineers, Philips' results were hit hard in the first half of 2020, as the pandemic caused hospitals to delay the installation of new equipment and crippled demand for consumer products.

But after the first shock of the coronavirus outbreak, Philips began to see a structural change at hospitals, Chief Executive Frans van Houten said, as they increased demand for devices that allow for remote patient monitoring.

These range from appliances for teleconsults to platforms for radiologists to diagnose patients while working from home and for monitoring patients on intensive care units without having to be by their side.

"There is a structural higher demand for the healthcare informatics that Philips has already invested in for several years and now we see the validation of that strategy", the CEO said.


This structural shift will be one of the main drivers for future growth, Van Houten said, as Philips updated its targets for the years to come.

Philips said it expected average sales growth of 5% to 6% per year between 2021 and 2025, with the adjusted EBITA margin improving by 60 to 80 basis points each year.

The company's profit margin jumped to 15.4% in the third quarter, up from 12.4% a year earlier, and is now expected to reach the "high teens" by 2025, it said.

For 2021, however, Philips predicted "low-single-digit growth", as demand for COVID-19 equipment is expected to cool down.

Philips cut its outlook for 2020 in August, after the U.S. Department of Health cancelled most of an order for 43,000 ventilators.

The company on Monday maintained its outlook for moderate sales growth and a stable EBITA margin for the whole of this year.

($1 = 0.8540 euros)

(Reporting by Bart Meijer; Editing by Muralikumar Anantharaman and Richard Pullin/Emelia Sithole-Matarise)

By Bart H. Meijer

© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
KONINKLIJKE PHILIPS N.V. 0.38% 42.805 Delayed Quote.0.35%
SIEMENS AG -0.89% 111.36 Delayed Quote.-3.59%
SIEMENS HEALTHINEERS AG 1.07% 37.95 Delayed Quote.-12.31%
11/25KONINKLIJKE PHILIPS N : Philips introduces industry-first vendor-neutral Radiolo..
11/25KONINKLIJKE PHILIPS N : Philips debuts AI-enabled automated Radiology Workflow S..
11/24KONINKLIJKE PHILIPS N : Philips debuts AI-enabled, automated Radiology Workflow ..
11/24KONINKLIJKE PHILIPS N : Philips debuts AI-enabled, automated Radiology Workflow ..
11/24Philips debuts AI-enabled, automated Radiology Workflow Suite at RSNA 2020
11/24KONINKLIJKE PHILIPS N : Philips introduces industry-first vendor-neutral Radiolo..
11/24KONINKLIJKE PHILIPS N : Philips introduces industry-first vendor-neutral Radiolo..
11/24Philips introduces industry-first vendor-neutral Radiology Operations Command..
11/23KONINKLIJKE PHILIPS N : Philips - Kees Wesdorp discusses sustainable healthcare ..
11/23KONINKLIJKE PHILIPS N : Philips' Precision Diagnosis Chief Business Leader highl..
More news
Sales 2020 19 611 M 23 364 M 23 364 M
Net income 2020 1 283 M 1 529 M 1 529 M
Net Debt 2020 3 319 M 3 954 M 3 954 M
P/E ratio 2020 30,6x
Yield 2020 2,03%
Capitalization 38 930 M 46 351 M 46 382 M
EV / Sales 2020 2,15x
EV / Sales 2021 2,08x
Nbr of Employees 80 718
Free-Float 99,7%
Duration : Period :
Koninklijke Philips N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KONINKLIJKE PHILIPS N.V.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 48,84 €
Last Close Price 42,81 €
Spread / Highest target 35,5%
Spread / Average Target 14,1%
Spread / Lowest Target -11,2%
EPS Revisions
Frans van Houten Chief Executive Officer
Jeroen van der Veer Chairman-Supervisory Board
Sophie Bechu Chief Operating Officer & Executive Vice President
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Jan Kimpen Chief Medical Officer
Sector and Competitors